Vanda Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	217.78	216.11	198.77	192.64	254.38	268.68
Revenue Growth (YoY)	8.16%	8.72%	3.18%	-24.27%	-5.32%	8.27%
Cost of Revenue	12.68	13.04	11.31	14.8	24.28	25.63
Gross Profit	205.1	203.06	187.46	177.84	230.1	243.05
Selling, General & Admin	256.23	237.95	146.41	112.88	136.49	124.05
Depreciation & Amortization Expenses	7.24	7.01	7.27	2.09	1.52	1.48
Research & Development	101.99	109.27	74.43	76.82	85.77	75.36
Total Operating Expenses	365.46	354.23	228.12	191.8	223.77	200.89
Operating Income	-160.36	-151.17	-40.66	-13.95	6.33	42.17
Total Non-Operating Income (Expense)	10.66	12.52	17.74	20.29	4.97	0.2
Pretax Income	-149.7	-138.65	-22.92	6.34	11.3	42.36
Provision for Income Taxes	89.84	81.83	-4.02	3.83	5.03	9.21
Net Income	-239.55	-220.47	-18.9	2.51	6.28	33.15
Net Income to Common	-239.55	-220.47	-18.9	2.51	6.28	33.15
Net Income Growth	-	-	-	-60.02%	-81.07%	42.06%
Shares Outstanding (Basic)	59	59	58	57	56	56
Shares Outstanding (Diluted)	59	59	58	58	57	57
Shares Change (YoY)	1.43%	1.34%	1.03%	1.01%	0.11%	3.14%
EPS (Basic)	-4.05	-3.74	-0.33	0.04	0.11	0.60
EPS (Diluted)	-4.05	-3.74	-0.33	0.04	0.11	0.58
EPS Growth	-	-	-	-63.64%	-81.03%	38.09%
Shares Outstanding	60.14	59.1	58.31	57.53	56.78	55.9
Free Cash Flow	-127.3	-110.44	-16.25	12.42	31.31	63.66
Free Cash Flow Growth	-	-	-	-60.33%	-50.83%	27.38%
Free Cash Flow Per Share	-2.15	-1.87	-0.28	0.22	0.55	1.12
Gross Margin	94.18%	93.96%	94.31%	92.32%	90.45%	90.46%
Operating Margin	-73.64%	-69.95%	-20.46%	-7.24%	2.49%	15.69%
Profit Margin	-109.99%	-102.02%	-9.51%	1.30%	2.47%	12.34%
FCF Margin	-58.45%	-51.10%	-8.17%	6.45%	12.31%	23.69%
EBITDA	-150.71	-139.25	-30.86	-9.62	9.06	45.01
EBITDA Margin	-69.20%	-64.44%	-15.53%	-4.99%	3.56%	16.75%
EBIT	-160.36	-151.17	-40.66	-13.95	6.33	42.17
EBIT Margin	-73.64%	-69.95%	-20.46%	-7.24%	2.49%	15.69%
Effective Tax Rate	-60.01%	-59.02%	17.54%	60.42%	44.47%	21.74%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q